Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Capital Region Retina, PLLC
mi
from
Albany, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Capital Region Retina, PLLC
mi
from
Albany, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Opthalmic Consultants of LI
mi
from
Lynbrook, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Opthalmic Consultants of LI
mi
from
Lynbrook, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Vitreous-Retina-Macula
mi
from
New York, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Vitreous-Retina-Macula
mi
from
New York, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Eye Associates; NewYork-Presbyterian Hospital/Weill Cornell Medical Center
mi
from
New York, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Eye Associates; NewYork-Presbyterian Hospital/Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Western New York
mi
from
Orchard Park, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Western New York
mi
from
Orchard Park, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Vit Surgeons/Central NY
mi
from
Syracuse, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Vit Surgeons/Central NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
West Carolina Retinal AssocPA
mi
from
Asheville, NC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
West Carolina Retinal AssocPA
mi
from
Asheville, NC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Char Eye Ear &Throat Assoc
mi
from
Charlotte, NC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Char Eye Ear &Throat Assoc
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Assoc. of Cleveland
mi
from
Cleveland, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Assoc. of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation; Cole Eye Institute
mi
from
Cleveland, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation; Cole Eye Institute
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
OSU Eye Physicians and Surgeons, LLC.
mi
from
Columbus, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
OSU Eye Physicians and Surgeons, LLC.
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Oregon Retina, LLP
mi
from
Eugene, OR
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Oregon Retina, LLP
mi
from
Eugene, OR
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Northwest, PC
mi
from
Portland, OR
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Northwest, PC
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Retinal Spec.
mi
from
Camp Hill, PA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Retinal Spec.
mi
from
Camp Hill, PA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Associates in Ophthalmology
mi
from
West Mifflin, PA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Associates in Ophthalmology
mi
from
West Mifflin, PA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Charleston Neuroscience Inst
mi
from
Ladson, SC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charleston Neuroscience Inst
mi
from
Ladson, SC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Charles Retina Institution
mi
from
Germantown, TN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charles Retina Institution
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
W Texas Retina Consultants PA
mi
from
Abilene, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
W Texas Retina Consultants PA
mi
from
Abilene, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
mi
from
Arlington, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Austin Retina Associates
mi
from
Austin, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Austin Retina Associates
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Research Center
mi
from
Austin, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Research Center
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Specialists
mi
from
DeSoto, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Specialists
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Med Center Ophthalmology Assoc
mi
from
San Antonio, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Med Center Ophthalmology Assoc
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Utah
mi
from
Salt Lake City, UT
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Univ of Virginia Ophthalmology
mi
from
Charlottesville, VA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Univ of Virginia Ophthalmology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Eye Surgeons of Richmond Inc. dba Virginia Eye Institute
mi
from
Richmond, VA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Eye Surgeons of Richmond Inc. dba Virginia Eye Institute
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Spokane Eye Clinical Research
mi
from
Spokane, WA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Spokane Eye Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
West Virginia University Eye Institute
mi
from
Morgantown, WV
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
West Virginia University Eye Institute
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Palmetto Retina Center, LLC
mi
from
Florence, SC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Palmetto Retina Center, LLC
mi
from
Florence, SC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Georgia Retina, P.C.
mi
from
Marietta, GA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Georgia Retina, P.C.
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
New Jersey Retina Research Foundation
mi
from
Edison, NJ
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
New Jersey Retina Research Foundation
mi
from
Edison, NJ
Click here to add this to my saved trials
Optimization of CRT Using an ECG Vest
Optimization of Cardiac Resynchronization Therapy Using an ECG Vest
Status: Enrolling
Updated:  12/31/1969
United Heart and Vascular Clinic
mi
from
Saint Paul, MN
Optimization of CRT Using an ECG Vest
Optimization of Cardiac Resynchronization Therapy Using an ECG Vest
Status: Enrolling
Updated: 12/31/1969
United Heart and Vascular Clinic
mi
from
Saint Paul, MN
Click here to add this to my saved trials
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
Prospective Registry of Patients With Ischemic Heart Failure Using the LifeVest Wearable Cardioverter Defibrillator (WEARIT-III)
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
Prospective Registry of Patients With Ischemic Heart Failure Using the LifeVest Wearable Cardioverter Defibrillator (WEARIT-III)
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Long Beach, CA
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Farmington Hills, MI
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Berlin, NJ
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
New York, NY
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Nashville, TN
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Dallas, TX
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
STOP Heart Disease in Breast Cancer Survivors Trial
Statin Therapy Operates to Prevent (STOP) Heart Disease in Breast Cancer Survivors Trial
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
STOP Heart Disease in Breast Cancer Survivors Trial
Statin Therapy Operates to Prevent (STOP) Heart Disease in Breast Cancer Survivors Trial
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Chapel Hill, NC
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Newark, DE
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Newark, DE
Click here to add this to my saved trials
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Baltimore, MD
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Baltimore, MD
Click here to add this to my saved trials